Genetic testing recommended for all patients with breast cancer. In a paper published in the journal Oncology on March 12, 2019, the American Society of Breast Surgeons (ASBS) have come to a consensus on new guidelines for patients with a history of breast cancer.
More than 15 oncology and breast health physicians contributed to the new guidelines. While there is a lack of consensus among some experts regarding which genes should be tested, all researchers involved, agree that all patients with a personal history of breast cancer should be offered genetic testing that includs BRCA1/2 and PALB2.
The new guidelines would have anyone diagnosed with breast cancer have genetic testing made available to them. When a patient’s diagnosis and health reports are complicated, the consensus is, genetic testing should be made available.
Furthermore, the researchers add, even patients who have already undergone genetic testing may benefit from updated testing.
Even people with no history of breast cancer but who meet other criteria should have genetic testing made available to them. Having an immediate family member with breast cancer history qualifies a person to be tested. Furthermore people who have familial history of breast cancer on either side of their families would qualify to be tested.
Access to Genetic Testing
According to these researchers, access to genetic testing for breast cancer is becoming more widely accepted now than in the past. Testing is becoming less expensive and covered by more health insurers.
Yet there are still some barriers such as limited availability of genetic counseling.
The new guidelines can be read here:
Consensus Guideline on Genetic Testing for Hereditary Breast Cancer